FDA approves Novartis drug Afinitor for breast cancer

(Reuters) – General Electric Co on Friday reported a 2.5 percent rise in profit from continuing operations, topping Wall Street expectations, as solid demand in the United States and emerging markets offset weakness in Europe. The largest U.S. conglomerate by revenue stuck with its forecast for the rest of 2012, saying …

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes